EDGAR Filing Documents for 0001477932-17-004572

Form CORRESP - Correspondence:

SEC Accession No. 0001477932-17-004572

Filing Date

2017-09-19

Accepted

2017-09-19 12:52:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	4166
	Complete submission text file	0001477932-17-004572.txt		5264

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations